ADHD medicine compared for kids with type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy, Mental health clinical trials.
This Phase 2 study compares two ADHD medicines—lisdexamfetamine and methylphenidate—in children who have ADHD and type 1 diabetes. It’s designed to see which option works better and is safe/effective for managing ADHD without causing major problems for diabetes care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 8 to 16.5 years old when the study starts
- Your child has type 1 diabetes for at least 12 months and uses intensive insulin therapy
- Your child has an ADHD diagnosis confirmed by a qualified professional
- Your child’s average blood sugar control is not too high (HbA1c must not be ≥12% over the past year)
- Your child does not have certain health or safety issues (heart problems, epilepsy, severe glaucoma, substance misuse, or pregnancy/breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This trial studies how ADHD stimulant medicine may change disruptive behaviors like aggression, tantrums, or refusing instructions. It may help clinicians understand whether stimulant dosing is supporting both ADHD symptoms and day-to-day behavior.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
Hear when a new Attention Deficit Disorder with Hyperactivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.